Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3M.P. Goetz, S. Johnston, Guido Van Hal et al.|Annals of Oncology|2024Cited by 204